Welcome!

News Feed Item

Advanced Cardiac Therapeutics Announces New Financing for Next Generation Temperature-Sensing Cardiac Ablation Catheter for Treatment of Cardiac Arrhythmias

- Led by New Enterprise Associates and Experienced Medical Device Industry Veterans, Financing Will Support Development of Next Generation TempaSure™ Radiometric Temperature-Sensing Radio-Frequency Ablation Catheter Capable of Accurate, Real-Time Volumetr

MENLO PARK, Calif., April 18, 2014 /PRNewswire/ -- Advanced Cardiac Therapeutics, Inc. ("ACT"), a medical device company that is developing a novel, temperature-sensing, irrigated, radiofrequency (RF) ablation catheter for treatment of cardiac arrhythmias, announced today the completion of a new round of equity financing as well as several key appointments to its Board of Directors. The financing, which was led by New Enterprise Associates ("NEA") and supported by existing investor, NBGI Ventures, will enable the Company to continue to advance its next generation TempaSure™ ablation catheters and related clinical development program.

In conjunction with the closing of the financing, ACT has made several key appointments to its Board of Directors. Justin Klein, Partner at NEA, has joined the Company's Board of Directors, along with Duke Rohlen, CEO at Ajax Vascular, who joins as the newly appointed Chairman of the Board. In addition, Mike Pederson, CEO of VytronUS and former VP & General Manager of Electrophysiology at Boston Scientific, has joined the Board as an independent director, and will work alongside current independent director, Roy Tanaka, the former the President of J&J Biosense Webster.

"We are fortunate to have Dr. Klein, Mr. Rohlen, and Mr. Pederson join ACT's Board of Directors. Their extensive investment and operating experience in the cardiovascular medical device industry will add valuable perspective to the Company as we move forward into our next phase of development," said Bill Olson, who will transition from CEO of ACT to an independent director on the Company's Board of Directors.

Commenting on NEA's investment, Dr. Klein stated, "We have closely followed the rapidly changing field of atrial fibrillation ablation and believe that ACT's proprietary TempaSure™ technology offers an innovative advancement in lesion creation and assessment that has the potential to improve clinical outcomes and procedure economics through enhanced accuracy and safety."

"Having seen the challenges associated with RF ablation over the last two decades, I'm excited to see a technology emerge that directly addresses the issue of real-time lesion assessment for catheter ablation," said Mike Pederson. "With promising early clinical results to support this novel technology, extensive intellectual property, and commitment to rigorous clinical science, we believe the Company is well-positioned to build a valuable new franchise opportunity in electrophysiology," added Duke Rohlen, newly appointed Chairman of the ACT Board of Directors.

Irrigated RF ablation catheters have become a mainstay device for treatment of atrial fibrillation and other cardiac arrhythmias. The introduction of catheter tip irrigation over a decade ago has allowed for safe use of higher energy levels resulting in improved outcomes, but impacted the ability of electrophysiologists to accurately control and assess tissue temperature, and by extension, maximize safe and effective lesion creation. ACT's TempaSure™ enabled irrigated RF ablation catheter leverages patent-protected microwave radiometry, which is not affected by saline irrigation, to accurately predict volumetric tissue temperature with a goal of restoring the clinician's ability to monitor lesion formation in real-time for a safer, more efficacious procedure.

ABOUT ATRIAL FIBRILLATION
According to the Heart Rhythm Society, atrial fibrillation is the most common sustained heart rhythm disorder with an estimated 12.5 million people worldwide who suffer from symptomatic AF. In atrial fibrillation, the electrical signals that coordinate contractions of the heart become rapid and disorganized, resulting in an irregular heartbeat that can increase the risk of stroke by fivefold. It is estimated that the global market for medical devices used in cardiac arrhythmia ablation, including diagnostic and ablation catheters as well as mapping and navigation systems exceeded $2.6 billion in 2013 with over 300,000 patients undergoing catheter and surgical ablations for treatment of AF.

ABOUT ADVANCED CARDIAC THERAPEUTICS
Advanced Cardiac Therapeutics, Inc., is a medical device company focused on developing an innovative temperature-sensing irrigated RF ablation catheter for treatment of cardiac arrhythmias. ACT's TempaSure™ technology features proprietary microwave radiometry technology that can accurately assess volumetric temperature in the heart in real time so that physicians can more precisely control and predict lesion formation for improved clinical outcomes. The Company is developing catheters for a range of ablation procedures, including atrial fibrillation, one of the fastest growing market opportunities in the medical device industry. 

ABOUT NEA

NEA is a leading venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With approximately $14 billion in committed capital, the firm invests in information technology, healthcare and energy technology companies at all stages in a company's lifecycle, from seed stage through IPO. NEA's long track record of successful investing includes more than 175 portfolio company IPOs and more than 300 acquisitions. For additional information, visit www.nea.com.

Contact:
Cynthia Yee
415-439-3010

SOURCE Advanced Cardiac Therapeutics, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Apache OpenWhisk on IBM Bluemix provides a powerful and flexible environment for deploying cloud-native applications driven by data, message, and API call events. In his session at 20th Cloud Expo, Daniel Krook, Software Architect, IBM Watson and Cloud Platform, and Distinguished IT Specialist, will discuss why serverless architectures are attractive for many emerging cloud workloads and when you should consider OpenWhisk for your next project. Then get started on Bluemix with three sample appl...
While presenting own advanced Robo-Advisory Platform, Michał Różański, Managing Partner at EARP and CEO at Empirica, will illustrate the most important issues of building tailored FinTech software in his session at 20th Cloud Expo. He will share experiences we have gained for over 6 years of developing solutions for financial institutions and FinTech companies, including robo-advisors. We welcome all FinTech innovators interested in how properly implemented technology can move their businesses f...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo Silicon Valley Call for Papers is now open.
The 21st International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
As cloud adoption continues to transform business, today's global enterprises are challenged with managing a growing amount of information living outside of the data center. The rapid adoption of IoT and increasingly mobile workforce are exacerbating the problem. Ensuring secure data sharing and efficient backup poses capacity and bandwidth considerations as well as policy and regulatory compliance issues.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, pane...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
SYS-CON Events announced today that Outscale will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outscale's technology makes an automated and adaptable Cloud available to businesses, supporting them in the most complex IT projects while controlling their operational aspects. You boost your IT infrastructure's reactivity, with request responses that only take a few seconds.
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
SYS-CON Events announced today that DivvyCloud will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. DivvyCloud software enables organizations to achieve their cloud computing goals by simplifying and automating security, compliance and cost optimization of public and private cloud infrastructure. Using DivvyCloud, customers can leverage programmatic Bots to identify and remediate common cloud problems in rea...
SYS-CON Events announced today that Tintri, Inc, a leading provider of enterprise cloud infrastructure, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Tintri offers an enterprise cloud platform built with public cloud-like web services and RESTful APIs. Organizations use Tintri all-flash storage with scale-out and automation as a foundation for their own clouds – to build agile development environments...